U
Reliq Health Technologies Inc. RHTH.V
TSX
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income 184.40% 96.93% 97.19% 57.26% 70.70%
Total Depreciation and Amortization -0.47% 2.35% -0.47% -25.82% 12.83%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 198.95% -97.22% -83.91% 9.99% -91.90%
Change in Net Operating Assets -177.85% -3.56% 15.36% -104.67% -30.21%
Cash from Operations 21.06% 10.40% 41.00% 17.59% 21.83%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 7.12% 13.43% 41.06% 141.21% -13.23%
Issuance of Common Stock -21.60% 40.66% -61.14% -41.00% 13.24%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -34.86% 31.48% -62.70% -45.58% 26.94%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -126.01% 117.82% -104.97% -220.87% 140.70%
Weiss Ratings